Mark Jackman

Director, Technology Evaluations and Transactions @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2024 — Present

Director, Technology Evaluations and Transactions @AstraZeneca

View department →

Cambridge, GB

EDUCATION

1998 — 2002

University of York

2:1, MChem Chemistry

2011 — 2015

The University of Manchester

PhD, Nanotechnology (Physics)

SKILLS

HplcNanotechnologyTitrationNmrValidationOrganic ChemistryNexafsSynchrotron RadiationTrace AnalysisCharacterizationBioanalyticalSpectroscopyXpsAnalytical ChemistrySolar Water SplittingAtomic Force MicroscopyTechnology TransferChromatographySurface ChemistryChemistryIcp-OesGc-MsXrfOrganic SynthesisCatalysisResearch and Development (R&D)High-Performance Liquid Chromatography (Hplc)Gas ChromatographyLcmsR&DMethod Development

ABOUT MARK JACKMAN

Director in Biopharmaceutics, Business Development and Licensing at AstraZeneca

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mark Jackman — Director, Technology Evaluations and Transactions at AstraZeneca in Cambridge, GB | Unifers